Chlamydomonas
j'ai reçu une proposition de recrutement dans une entreprise de biotechnologie Taiwanaise/Chinoise
"We were founded in 2012 and have raised over US$215 million and with the aim to be IPO in HK by end of the year. We are focused on development and GMP certified manufacturing of proprietary biosimilars, in five years we already filed 3 products for phase 1/3 clinical trails. With the continuation of expansion of our business and next molecules, we eagerly seek for Taiwan Biotech Talents. "
"We were founded in 2012 and have raised over US$215 million and with the aim to be IPO in HK by end of the year. We are focused on development and GMP certified manufacturing of proprietary biosimilars, in five years we already filed 3 products for phase 1/3 clinical trails. With the continuation of expansion of our business and next molecules, we eagerly seek for Taiwan Biotech Talents. "
